Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Miraca Holdings Inc.    4544   JP3822000000

MIRACA HOLDINGS INC.

(4544)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Miraca Holdings Inc. is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and healthcare related business. The Company operates in three business segments. The Clinical Diagnostic segment is engaged in the manufacture and sale of clinical diagnostics. The Entrusted Clinical Examination segment is involved in entrusted clinical examinations from medical institutions. The Healthcare segment is engaged in the provision of sterilization services and clinical trial services, as well as the rental of nursing care products.

Number of employees : 5 957 people.
Sales per Businesses
20182019Delta
JPY (in Million)%JPY (in Million)%
Commissioned Clinical Testing121,95862.4%108,08459.6% -11.38%
Chemical Clinical Testing45,31123.2%45,39925% +0.19%
Health Care-related28,13014.4%27,93115.4% -0.71%
Sales per Regions
20182019Delta
JPY (in Million)%JPY (in Million)%
Japan156,82380.3%159,63988% +1.8%
United States23,48312%6,5193.6% -72.24%
Europe11,3295.8%11,4406.3% +0.98%
Other3,7651.9%3,8152.1% +1.33%
Managers
NameAgeSinceTitle
Shigekazu Takeuchi662017President, Group CEO & Representative Director
Naoki Kitamura492018Chief Financial Officer & Director
Hiroaki Kimura582012Head-Information Technology & Investor Relations
Kazuya Omi--Executive Officer, Head-Research & Development
Ryoji Itoh672014Independent Outside Director
Miyuki Ishiguro552013Outside Director
Yamauchi Susumu702017Independent Outside Director
Futomichi Amano662017Independent Outside Director
Shigehiro Aoyama722018Outside Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 0.01 57,387,861 56,865,563 99.1% 404,738 0.7% 99.1%
Shareholders
NameEquities%
International Value Advisers LLC 8,128,700 14.2%
DWS Investments (UK) Ltd. 2,293,359 4.00%
Mizuho Bank Pension Fund 2,131,500 3.71%
T. Rowe Price Associates, Inc. (Investment Management) 2,059,200 3.59%
Asset Management One Co., Ltd. 2,014,600 3.51%
Dai-ichi Life Holdings, Inc. 2,000,700 3.49%
Nomura Asset Management Co., Ltd. 1,892,474 3.30%
Fidelity Management & Research Co. 1,798,694 3.13%
FIL Investments (Japan) Ltd. 1,788,738 3.12%
JPMorgan Asset Management (Japan) Ltd. 1,722,806 3.00%
Holdings
NameEquities%Valuation
JEOL Ltd. (6951) 257,0000.53%7,840,759 USD
Miraca Holdings Inc. (4544) 255,5000.45%6,289,917 USD
Morpho, Inc. (3653) 100,8001.87%2,955,049 USD
Sapporo Clinical Laboratory Inc. (9776) 169,0004.01%2,918,365 USD
FALCO HOLDINGS Co., Ltd. (4671) 45,5000.40%770,267 USD
Toho Holdings Co., Ltd. (8129) 22,2750.028%496,045 USD
Suzuken Co., Ltd. (9987) 11,9790.012%490,767 USD
Alfresa Holdings Corporation (2784) 7,3720.0031%150,707 USD
Vital KSK Holdings, Inc. (3151) 13,2300.022%127,341 USD
Trans Genic Inc. (2342) 4320.0025%1,593 USD
Company contact information
Miraca Holdings, Inc.
Shinjuku Mitsui Building, 8/F
2-1-1 Nishi-Shinjuku
Shinjuku-Ku
Tokyo 163-0408

Phone : +81.3.5909.3335
Fax : +81.3.5909.3336
Web : http://www.miraca-holdings.co.jp
Sector Bio Diagnostics & Testing
1st jan.Capitalization (M$)
MIRACA HOLDINGS INC.1.69%1 402
GUARDANT HEALTH, INC.8.27%7 944
GENSCRIPT BIOTECH CORPORATION6.09%4 551
IOVANCE BIOTHERAPEUTICS, INC.-13.75%3 013
INVITAE CORPORATION21.70%1 895
VERACYTE, INC.7.99%1 473
CAREDX, INC9.46%1 002
SEEGENE INC--.--%695
INNATE PHARMA15.02%597
EPIGENOMICS AG4.03%69
LYSOGENE63.64%45